antimalarial
Showing 1 - 25 of 544
l Antimalarial Drugs, Malaria Vaccines, and Controlled Human
Recruiting
- Malaria
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Malaria, Malaria,Falciparum Trial in Ouagadougou (Seasonal Malaria Chemoprophylaxis (under 5 year old) implemented by the MoH
Not yet recruiting
- Malaria
- Malaria,Falciparum
- Seasonal Malaria Chemoprophylaxis (under 5 year old) implemented by the MoH without DOT
- +2 more
-
Ouagadougou, Burkina FasoGroupe de Recherche Action en Santé
May 18, 2023
Plasmodium Falciparum Antimalarial Drug Resistance Markers
Completed
- Plasmodium Falciparum
-
Kome, Doba, ChadStudy clinic
Mar 29, 2022
Lupus Erythematosus, Cutaneous, Subacute, Chronic Cutaneous Lupus Erythematosus Trial (BIIB059 (litifilimab))
Not yet recruiting
- Lupus Erythematosus, Cutaneous, Subacute
- Chronic Cutaneous Lupus Erythematosus
- BIIB059 (litifilimab)
- (no location specified)
Sep 12, 2023
Monitoring Pregnant Women for Antimalarial Drug Resistance
Recruiting
- Malaria
- Malaria screening
-
Kinsasa, Congo, The Democratic Republic of theKinshasa Medical Oxford Research Unit
Nov 25, 2021
Cutaneous Lupus Erythematosus Trial (Anifrolumab, Placebo)
Not yet recruiting
- Cutaneous Lupus Erythematosus
- Anifrolumab
- Placebo
- (no location specified)
Aug 22, 2023
MALARIA Trial in Niamey (Artemether-lumefantrine)
Completed
- MALARIA
-
Niamey, NigerProgramme National de Lutte Contre Le Paludisme
Oct 5, 2021
Uncomplicated Plasmodium Falciparum Trial in Tambolaka (Dihydroartemisinin, Piperaquine, Primaquine)
Completed
- Uncomplicated Plasmodium Falciparum
- Dihydroartemisinin
- +3 more
-
Tambolaka, East Nusa Tenggara, IndonesiaKori Puskesmas
Apr 27, 2023
Malaria Genetic Surveillance
Recruiting
- Plasmodium Falciparum and Plasmodium Vivax
-
Phnom Penh, Cambodia
- +2 more
Mar 22, 2022
Rabies Trial in Syracuse (Chloroquine, Atovaquone and Proguanil, Doxycycline)
Completed
- Rabies
- Chloroquine
- +3 more
-
Syracuse, New YorkState University of New York, Upstate Medical University (SUNY-U
Apr 22, 2021
Uncomplicated Plasmodium Falciparum Malaria Trial in Congo, The Democratic Republic of the (Artesunate-amodiaquine,
Recruiting
- Uncomplicated Plasmodium Falciparum Malaria
-
Kapolowe, Haut-Katanga, Congo, The Democratic Republic of the
- +7 more
Oct 7, 2023
MiMBa Pregnancy Registry
Recruiting
- Malaria in Pregnancy
- +2 more
-
Kisumu, KenyaKenya Medical Research Institute
Mar 30, 2021
Malaria Trial in New Orleans (AQ-13)
Completed
- Malaria
-
New Orleans, LouisianaTulane-LSU General Clinical Research Center
Dec 4, 2020
Malaria Trial in New Orleans (AQ-13, Chloroquine (CQ) Treatment)
Completed
- Malaria
- AQ-13
- Chloroquine (CQ) Treatment
-
New Orleans, LouisianaTulane-LSU-Charity Hospital General Clinical Research Center
Dec 4, 2020
Malaria Trial in Congo, The Democratic Republic of the (Artesunate-amodiaquine, Artemether-lumefantrine)
Completed
- Malaria
-
Kapolowe, Haut-Katanga, Congo, The Democratic Republic of the
- +5 more
Feb 8, 2022
Plasmodium Falciparum, Malaria Trial in Tübingen (DSM265 400mg, Placebo to DSM265 400 mg, Plasmodium falciparum sporozoite
Completed
- Plasmodium Falciparum, Malaria
- DSM265 400mg
- +3 more
-
Tübingen, GermanyUniversitätsklinikum Tübingen, Institut für Tropenmedizin
Jan 7, 2021
Malaria Trial in Antwerpen (P218 (1000 mg) Oral Capsules, Placebo Oral Capsules, P218 (100 mg) Oral Capsules)
Completed
- Malaria
- P218 (1000 mg) Oral Capsules
- +3 more
-
Antwerpen, BelgiumSGS Belgium NV Clinical Pharmacology Unit
Mar 16, 2021
Malaria Trial in Herston (DSM265, OZ439)
Terminated
- Malaria
-
Herston, Queensland, AustraliaQ-Pharm Clinics
May 25, 2020
Covid19 Trial in Conakry (Hydroxycloroquine and Azythromycine, Cospherunate/Azythromycine,
Unknown status
- Covid19
- Hydroxycloroquine and Azythromycine
- +2 more
-
Conakry, GuineaDonka; Kenien; Gbessia
Aug 5, 2020
T Cell Suppression: Antimalarial Treatment and Vaccine Responses
Completed
- Malaria
-
Bamako, MaliMalaria Research and Training Center
Dec 14, 2019
Malaria Trial in Herston (MMV390048 40 mg, Placebo to match MMV390048 40 mg, MMV390048 80 mg)
Completed
- Malaria
- MMV390048 40 mg
- +5 more
-
Herston, AustraliaQ Pharm Clinics
May 26, 2020
Drugs That Could Prevent Risk of Serious COVID-19 Infections or
Unknown status
- AMD, ACEi's/ARB Prevent/Worsen Risk of COVID-19 Infection
- - Synthetic anti-malarial drugs
-
Créteil, FranceAssistance Publique Hôpitaux de Paris - CHU Henri Mondor
Apr 17, 2020
Malaria Trial in Nanoro (Sulfadoxine pyrimethamine, Amodiaquine)
Recruiting
- Malaria
- Sulfadoxine pyrimethamine
- Amodiaquine
-
Nanoro, Burkina FasoUnité de Recherche Clinique de Nanoro
Jul 26, 2022
Severe Malarial Treatment Trial in Lambaréné (artesunate-pyronaridine)
Not yet recruiting
- Severe Malarial Treatment
-
Lambaréné, Moyen- Ogooué, GabonCentre de Recherches Médicales de Lammbaréné
Jun 26, 2023